Contract Notice Detail

Summary Information

Summary Information
1,458.945600 Euro
 
10C0720024 
Aquisição de IPRATROPIO+SALBUTAMOL, AMP 2,5 ML,INAL, ao abrigo do CPA 2021/12, para a ULSASI, para o ano 2024 
Tendering Phase
Awarded
Aquisição de IPRATROPIO+SALBUTAMOL, AMP 2,5 ML,INAL, ao abrigo do CPA 2021/12, para a ULSASI, para o ano 2024 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
B526 - BROMETO DE IPRATRÓPIO + SALBUTAMOL [0.5 MG/2.5 ML + 2.5 MG/2.5 ML;SOL INAL NEB; AMP]-154 (Days)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
7/30/2024 10:44 AM (UTC +1 hour)
 
10/4/2021 10:40 AM (UTC +1 hour)
 
8/1/2024 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Anexo II.xlsxAnexo II.xlsxAdditional InformationDownload
Convite_10C0720024.pdfConvite_10C0720024.pdfInstruction to tenderersDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
B526 - BROMETO DE IPRATRÓPIO + SALBUTAMOL [0.5 MG/2.5 ML + 2.5 MG/2.5 ML;SOL INAL NEB; AMP]
Base Price
1 458,945600

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
B526 BROMETO DE IPRATRÓPIO + SALBUTAMOL [0.5 MG/2.5 ML + 2.5 MG/2.5 ML;SOL INAL NEB; AMP] 5 600,000000 UN
Buyer Comment: 500293023 | Boehringer Ingelheim Portugal, Lda. | CPA:2021012/176/0031 | NºAIM:3218682; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2021012/334/0015 | NºAIM:5071410;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - B526 - BROMETO DE IPRATRÓPIO + SALBUTAMOL [0.5 MG/2.5 ML + 2.5 MG/2.5 ML;SOL INAL NEB; AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.Preço-100%

Normas de desempate

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...